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Abstract
Background: Metabolic syndrome is a multi-component disorder associated to a high risk of cardiovascular disease.
Its etiology is the result of a complex interaction between genetic and environmental factors, including dietary
habits. We aimed to identify the target proteins modulated by the long-term consumption of four diets differing in
the quality and quantity of lipids in the whole proteome of peripheral blood mononuclear cells (PBMC).
Results: A randomized, controlled trial conducted within the LIPGENE study assigned 24 MetS patients for 12 weeks
each to 1 of 4 diets: a) high-saturated fatty acid (HSFA), b) high-monounsaturated fatty acid (HMUFA), c) low-fat,
high-complex carbohydrate diets supplemented with placebo (LFHCC) and d) low-fat, high-complex carbohydrate
diets supplemented with long chain (LC) n-3 polyunsaturated fatty acids (PUFA) (LFHCC n-3). We analyzed the
changes induced in the proteome of both nuclear and cytoplasmic fractions of PBMC using 2-D proteomic analysis.
Sixty-seven proteins were differentially expressed after the long-term consumption of the four diets. The HSFA diet
induced the expression of proteins responding to oxidative stress, degradation of ubiquitinated proteins and DNA
repair. However, HMUFA, LFHCC and LFHCC n-3 diets down-regulated pro-inflammatory and oxidative stress-related
proteins and DNA repairing proteins.
Conclusion: The long-term consumption of HSFA, compared to HMUFA, LFHCC and LFHCC n-3, seems to increase the
cardiovascular disease (CVD) risk factors associated with metabolic syndrome, such as inflammation and oxidative stress,
and seem lead to DNA damage as a consequence of high oxidative stress.
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Background
Metabolic syndrome (MetS) is a multi-component dis-
order characterized by abdominal obesity, dyslipidaemia,
hypertension and impaired insulin sensitivity, and it is
associated with an increased risk of type 2 diabetes
(T2DM) and cardiovascular diseases (CVD) [1, 2]. The
etiology of MetS is the result of a complex interaction
between genetic and environmental factors, including
dietary habits, particularly the quality of dietary lipids [3].
MetS is also associated to a low-grade inflammation,
which links MetS patients with atherosclerosis risk
development [4]. Additionally, MetS patients have in-
creased oxidative stress, which is directly related to the
inflammatory process [5]. Reactive oxygen species (ROS)
also trigger alterations in biomolecules such as lipids,
proteins and DNA, which in turn, activate cellular sys-
tems to repair the proteins and DNA [6].
Diet, and particularly dietary lipids, has been shown to
modulate these processes [7, 8]. In fact, monounsatu-
rated fatty acids (MUFA)-rich diets reduce NF-κB activa-
tion compared with butter- and walnut-enriched diets or
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Western diets [9], and reduce the pro-inflammatory and
oxidative status [10–12]. In addition, low-calorie [13] and
MUFA-rich [14] diets reduce oxidative stress. Moreover,
the consumption of saturated fatty acids has been shown to
contribute to the development of MetS by producing pro-
inflammatory cytokines such as tumor necrosis factor-α
(TNF-α) and interleukin-6 via NF-kB activation [1].
Many studies use as an in vivo cellular model periph-
eral blood mononuclear cells (PBMC), a subset of white
blood cells consisting of lymphocytes and monocytes/
macrophages, which are easily isolated in humans from
blood samples and frequently used to assess biological
responses [15–17], including dietary intervention [18–20].
Most of them analyze gene expression, and while this is
relevant, they have the intrinsic limitation of not focusing
on the final products that perform the biological function.
In fact, we have previously shown in a sub-group of the
Lipgene study (which the population of this study belongs
to) how an increased expression of antioxidant genes in
PBMC seems to be due to the response to the postpran-
dial oxidative stress generated mainly in adipose tissue
after the consumption of an high-saturated fatty acid
diet (HSFA). We have also shown how the long-term
consumption of a healthy diet model with high-
monounsaturated fatty acid (HMUFA) attenuates the
postprandial inflammatory state and oxidative stress
associated with MetS [19–21]. These gene expression
changes were supported by changes in the regulatory
elements at protein levels, so it may be expected that
the diet would cause changes in the proteome.
A proteomic approach using two-dimensional poly-
acrylamide gel electrophoresis (2D-PAGE) coupled with
mass spectrometry protein identification is becoming
widely used as a tool for monitoring changes in protein
expression which may be associated to a specific disease
or therapeutic response [22], including dietary inter-
vention [23].
We recently described the changes undergone by the
proteome after the intake of four different meals in
terms of lipid quality [24]. Although that study allowed
us to identify fast-response proteins for dietary lipids
which respond to an acute intake, it raised questions
about the effect of the long-term consumption of dietary
models differing in quantity and quality of lipids. Thus,
in this work, we aimed to assess the changes in the
proteome of MetS patients after 12 weeks’ consumption
of the four dietary models, in order to identify the target
proteins that are modulated in response to the quantity
and quality of lipids.
Results
Baseline and post-intervention metabolic characteristics
No significant differences were observed in the baseline
or post-intervention metabolic characteristics of the 24
subjects with MetS participating in the dietary interven-
tion. In addition, we have not found any differences in
the fasting levels of lipids and metabolic parameters after
the consumption of the diets as compared with the base-
line (Table 1).
Proteomic analysis
Our proteomic 2-D PAGE analysis of the changes in the
proteome of PBMC, at the level of nuclear and cytoplas-
mic fractions separately, after the long-term intake of
the four different diets, showed an average of >250 pro-
tein spots detected in the nuclear fraction and > 350 pro-
tein spots detected in the cytoplasmic fraction.
The long-term consumption of the four diets (12-week
dietary intervention) induced significant changes in the
proteome of PBMC in both nuclear (Table 2; see Additional
file 1: Table S1) and cytoplasmic fractions (Table 3; see
Additional file 2: Table S2). In the nuclear fraction, we
observed significant changes in 29 proteins. The long-term
consumption of the HSFA diet induced the up-regulation
of 4 proteins (CHMB1.5, ASB11, VASP, NFX1) and the
down-regulation of 2 proteins (ACTB and ARPC2). The
consumption of the HMUFA diet induced the up-
regulation of ZSCAN29 protein and the down-regulation
of 8 proteins (VPS28, TLN1, GSN, FGB, FGA, F2,
POLR3E, ANX2). The consumption of LFHCC induced
the up-regulation of 2 proteins, GSN and ZFP624, and the
down-regulation of 8 proteins (THBS1, TPM, REV3-L,
MYO1, MACF1, FGB, CAP and one hypothetical protein)
while the consumption of LFHCC with n-3 fatty acids
caused the up-regulation of 6 different proteins (FGG,
VCL, PA2G4, MSN, PLEK, FGB) and the down-regulation
of CLIC1 protein.
In the cytoplasmic fraction, we observed significant
changes in 25 proteins after the long-term consumption
of the four diets. The long-term consumption of the
HSFA diet induced the up-regulation of 3 proteins
(TOM1, POLR3E and Chain A, X-Ray Crystal Structure
of Zinc-Bound carbonic Anhydrase (Caii)), and the down-
regulation of CCDC88B protein. The consumption of the
HMUFA diet caused the up-regulation of ZFP791 protein
and the down-regulation of 5 proteins (CLIC1, PDIA5,
CAPZ, hCG1808619, NRIP3). The LFHCC diet induced
the up-regulation of PSMA4 protein and the down-
regulation of 5 proteins (hCG2041202, TBK1, GRB2, Sry-
related protein, VDAC2) while the LFHCC with n-3 fatty
acids caused the up-regulation of 4 proteins (VPS28, BiP,
S4-SRCRB, GSN) and the down-regulation of 6 proteins
(CLIC1, ACTB, POTE-2, CAPZ, HSP70-2, MACF1).
Relationship between MetS and proteome changes
In order to evaluate the relationship between the MetS
and the changes in the proteome, we performed a Pearson
correlation analysis between the fold change of the
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MetS parameters and the fold change of the protein dif-
ferentially expressed by the diets (Table 4). We observed
a positive relationship in the fold change of GSN and
CLIC1 levels (R = 0.871, p = 0.024, and R = 0.971, p = 0.006,
respectively), and a negative relationship in the fold
change of F2 and CAPZ levels (R = −0.920, p = 0.009,
and R = −0.915, p = 0.030, respectively), with that of the
TAG levels. In addition, we observed a positive relation-
ship in the fold change of CAPZ and PMSA4 (R = 0.951,
p = 0.013, and R = 0.879, p = 0.049, respectively), and a
negative relationship in the fold change of PLEK (R =−0.820,
p= 0.046), with that of glucose levels. We also found a
positive relationship between FGA and PLEK (R = 0.894,
p = 0.041, and R = 0.842, p = 0.036, respectively), and the
fold change of the waist perimeter.
Pathway analysis
Pathway analysis was performed by using the Ingenuity
Pathway program, which allowed us to identify those
metabolic pathways or possible biomechanisms that may
be regulated in response to the long-term consumption
of the four different diets. These biomechanisms can be
grouped in 6 clusters of cellular functions: (A) movement,
proliferation and migration of cells (ANX2, F2, FGA,
GRB2, BiP, MSN, PA2G4, THBS1, TLN1, TPM1, VASP,
VASP28, VCL), (B) cellular assembly and organization
(ARPC2, F2, PLEK, TBK1, THBS1, TPM1, (C) regulation
and metabolism (NFX1, CC88B, S100A10), (D) chaper-
ones and stress response (VDAC2, HSPA1A, HSPA1B,
BiP), (E) cellular cycle (MYO1, NFX1), (F) DNA integrity
(REV3-L, PSMA4, POLR3E), (F) others (NRIP3, ZNF624,
ZNF791, ZSCAN2).
Our analysis also showed that the long-term consump-
tion of the HSFA diet induced changes in proteins involved
in five interaction networks (Fig. 1a), which are mainly re-
lated with the degradation of unfolding proteins (nuclear
CHMP1.5), cell to cell signaling interaction (nuclear VASP
and cytoplasmic TOM1), morphology and cardiovascular
system development (nuclear ARPC2). Analysis of the bio-
functions related with diseases and disorders showed that
these proteins are included in neurological (p = 5.8E-04–
1.2E-02) and infectious diseases (CHMP.5 and ACTB)
(p = 8.5E-03 – 8.5E-03). Top canonical pathway analysis
showed the interaction of three nuclear proteins ACTB,
ARPC2 and VASP within the pathway Fcγ receptor-
mediated phagocytosis in macrophages and monocytes
[p = 1.55E-05; ratio 3/95 (0.032)].
The long-term consumption of the HMUFA diet in-
duced changes in proteins involved in three different
networks (Fig. 1b): developmental disorder (nuclear
FGA, FGB, ACTB and GSN), DNA replication, recom-
bination and repair (nuclear POLR3E) and inflammatory
response (nuclear F2, TLN1, GSN and cytoplasmic CAPZ).
The molecular and cellular functions analysis included
the proteins involved in mechanisms such as cell to cell
signaling (FGA, FGB, F2 and TLN1), cell function and
maintenance (GSN), and cell death and survival (F2,
GSN and VPS28). In terms of diseases and disorders,
Table 1 Baseline characteristics of 24 subjects with the MetS assigned to each diet
Characteristics HSFA HMUFA LFHCC LFHCC n-3 p-value
Age (years) 59.5 ± 3.9 52.5 ± 6.6 61.2 ± 5.2 54.0 ± 11.0 0.142
BMI (kg/m2) 36.8 ± 2.4 33.7 ± 4.3 35.2 ± 3.4 34.3 ± 3.8 0.483
Pre-intervention
Waist circumference 118.7 ± 6.4 108.1 ± 6.4 111.7 ± 10.8 107.1 ± 7.5 0.085
TC (mg/dl) 193.9 ± 23.4 194.3 ± 36.5 188.0 ± 49.7 190.9 ± 34.7 0.990
TAG total (mg/dl) 132.0 ± 57.3 135.3 ± 54.8 128.6 ± 32.8 138.0 ± 66.9 0.992
LDL-c (mg/dl) 130.5 ± 24.1 141.7 ± 25.4 133.7 ± 38.9 130.3 ± 33.8 0.911
HDL-c (mg/dl) 44.5 ± 3.4 39.5 ± 11.4 40.4 ± 9.4 43.8 ± 8.7 0.658
Glucose (mg/dl) 109.4 ± 12.9 112.1 ± 14.1 102.3 ± 9.2 114.0 ± 20.0 0.536
Insulin (mU/ml) 18.4 ± 6.3 10.9 ± 4.5 14.5 ± 6.3 13.0 ± 5.5 0.175
Post-intervention
Waist circumference 119.1 ± 2.9 108.5 ± 3.3 111.2 ± 4.4 108.8 ± 2.6 0.125
TC (mg/dl) 192.3 ± 7.9 191.3 ± 6.6 175.6 ± 15.8 172.3 ± 11.09 0.458
TAG total (mg/dl) 107.3 ± 27.3 136.3 ± 17.6 133.0 ± 15.8 109.5 ± 18.5 0.455
LDL-c (mg/dl) 132.5 ± 6.9 135.0 ± 6.7 122.6 ± 14.6 112.9 ± 10.7 0.427
HDL-c (mg/dl) 43.5 ± 2.1 40.1 ± 2.1 38.3.4 ± 1.8 44.6 ± 2.3 0.384
Glucose (mg/dl) 103.5 ± 4.8 107.1 ± 6.0 103.8 ± 10.3 107.7 ± 8.9 0.972
Insulin (mU/ml) 16.7 ± 2.2 15.3 ± 2.2 14.5 ± 2.9 13.5 ± 1.0 0.770
Values presented are the mean ± SEM of each diet group. One-way ANOVA statistical analysis p-values
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Table 2 Long-term effect of quantity and quality of dietary fat on proteome of the nuclear fraction of PBMC
Proteomic changes Induced after 12 weeks of the intake of HSFA diet consumption
Protein Symbol FC p-Value
- Beta actin partial ACTB 0.56 0.041
- Charged multivesicular body protein 1b CHMB1.5 2.64 0.038
- Actin related protein 2/3 complex, subunit 2, 34 kDa,isoform ARPC2 DR 0.009
- Ankyrin repeat and SOCS box protein 11 ASB11 1.98 0.049
- Vasodilator-stimulated phosphoprotein VASP 3.51 0.041
- Transcriptional repressor NF-X1 NFX1 UR 0.009
Proteomic changes Induced after 12 weeks of the intake of HMUFA diet consumption
Protein Symbol FC p-Value
- Vacuolar protein sorting-associated protein 28 homolog VPS28 DR 0.003
- Talin 1 TLN1 0.50 0.036
- Zinc finger and SCAN domain-containing protein 29 ZSCAN29 1.83 0.031
- Gelsolin GSN 0.35 0.043
- Fibrinogen, beta chain isoform CRA e FGB 0.33 0.038
- Alpha-fibrinogen precursor FGA 0.04 0.044
- Chain B, Crystal Structure Of The Thrombin MutantG193p F2 0.53 0.015
- DNA-directed RNA polymerase III subunit POLR3A 0.27 0.034
- Annexin A2 ANX2 0.33 0.050
Proteomic changes Induced after 12 weeks of the intake of LFHCC diet consumption
Protein Symbol FC p-Value
- Thrombospondin 1 precursor THBS1 0.34 0.019
- Putative tropomyosin alpha-3 chain-like protein TPM 0.53 0.030
- REV3-like, catalytic subunit of DNA polymerase zeta REV3-L 0.21 0.001
- Myosin-1 MYO1 0.25 0.039
- Microtubule-actin cross-linking factor 1 MACF1 0.54 0.015
- Fibrinogen beta chain FGB 0.40 0.045
- Adenylate cyclase-associated protein 1 (yeast) CAP DR 0.009
- Gelsolin GSN 6.16 0.024
- Hypothetical protein 0.71 0.024
- Zinc finger protein 624 ZFP624 1.61 0.034
Proteomic changes Induced after 12 weeks of the intake of LFHCC + n3 diet consumption
Protein Symbol FC p-value
- Fibrinogen gamma chain, isoform CRA_j FGG 1.88 0.048
- Vinculin VCL 3.23 0.026
- Proliferation associated 2G4 protein PA2G4 2.17 0.001
- Moesin MSN 2.61 <0.05
- Pleckstrin PLEK 1.84 0.025
- Fibrinogen beta chain FGB 1.85 0.039
- Chloride intracellular channel 1 protein CLIC1 DR <0.50
- Fibrinogen beta chain, isoform CRA_d FGB 4.90 <0.50
Proteins differentially expressed in the post-intervention compared to the baseline from an average of over 250 protein spots detected in the nuclear fraction.
FC: Fold change. T-test p-value. UR, up-regulated proteins, not detected at baseline but detected at post-intervention. DR, down- regulated, proteins detected at baseline
but not detected at post-intervention
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the biofunctions analysis showed two items at the level
of hematological and immunological diseases, with five
proteins inter-related (FGB, FGA, ANXA2, GSN and F2).
Analysis of the canonical pathways indicates that the
protein changes identified interact in pathways related
with extrinsic and intrinsic prothrombin activation and
the coagulation system (p = 8.0E-10; 9.0E-09; 2.3E-08;
respectively).
Long-term consumption of the LFHCC diet showed
significant changes in the proteins interlinked in one
main network (Fig. 2a), that includes six molecules related
with organism function (nuclear CAP, GSN, TPM, THBS1
and cytoplasmic GRB2, TBK1), tissue morphology, organ-
ism injury and abnormalities. Analysis of the molecular
and cellular functions suggests that these proteins are in-
volved in the carbohydrate metabolism, cell to cell signaling
(THBS1 and GRB2) and cellular assembly and organization
(nuclear GSN, CAP, THBS1, MYO1, TPM, and cytoplasmic
GRB2, TBK). Our results showed that at the level of
the biofunctions related with diseases and disorders,
Table 3 Long-term effect of quantity and quality of dietary fat on proteome of cytoplasmic fraction of PBMC
Proteomic changes Induced after 12 weeks of the intake of HSFA diet consumption
Protein Symbol FC p-Value
- Target of Myb protein 1 TOM1 2.06 0.027
- DNA-directed RNA polymerase III subunit POLR3E 3.08 0.012
- Chain A, X-Ray Crystal Structure Of Zinc-Bound F95mW97V CARBONIC Anhydrase (Caii) Variant UR 0.017
- Coiled-coil domain-containing protein 88B. Isoform 3 CCDC88B DR 0.026
Proteomic changes Induced after 12 weeks of the intake of HMUFA diet consumption
Protein Symbol FC p-Value
- Chloride intracellular channel 1 protein CLIC1 0.63 0.032
- Protein disulfide isomerase-related protein 5 PDIA5 0.47 0.008
- Capping protein (actin filament) muscle Z-line, beta CAPZ 0.32 0.024
- hCG1808619 DR 0.024
- Nuclear receptor-interacting protein 3 NRIP3 DR 0.023
- Zinc finger protein 791 ZFP791 1.89 0.038
Proteomic changes Induced after 12 weeks of the intake of LFHCC diet consumption
Protein Symbol FC p-Value
- hCG2041202 0.62 0.001
- NF-kappa-B-activating kinase TBK1 0.62 0.019
- Growth factor receptor-bound protein 2 isoform 1 GRB2 0.35 0.026
- Sry-related HMG box gene 0.16 0.007
- PSMA4 protein PSMA4 1.81 0.071
- Voltage-dependent anion channel 2, isoform CRA_a VDAC2 0.70 0.046
Proteomic changes Induced after 12 weeks of the intake of LFHCC + n3 diet consumption
Protein Symbol FC p-Value
- Vacuolar protein sorting-associated protein 28 homol VPS28 1.85 0.040
- BiP Protein BiP 1.77 0.029
- Chloride intracellular channel 1 protein CLIC1 0.40 0.013
- Beta actin ACTB DR <0.05
- POTE-2 alpha actin POTE-2 0.38 0.014
- Capping protein (actin filament) muscle Z-line, beta CAPZ DR <0.05
- HSP70-2 HSP70-2 0.35 0.049
- Microtubule-actin cross-linking factor 1 MACF1 DR <0.05
- S4-SRCRB 4.05 0.009
- Gelsolin GSN 1.67 0.023
Proteins differentially expressed in the post-intervention compared to the baseline from an average of over 350 protein spots detected in the cytoplasmic fraction.
FC: Fold change. T-test p-value. UR, up-regulated proteins, not detected at baseline but detected at post-intervention. DR, down- regulated, proteins detected at
baseline but not detected at post-intervention
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the changes induced by a chronic intake of the LFHCC
diet are implicated in cardiovascular and metabolic
diseases (TPM, GSN and THBS1). The canonical path-
way analysis shows that the changes identified are re-
lated with actin cytoskeleton signaling (ACTB, GSN,
GRB2) (p = 8.5E-04).
The LFHCC n-3 diet induced changes in the proteome
of PBMC (Fig. 2b) related with the inflammatory response
(nuclear FGB, FGG, VCL, and cytoplasmic ACTB, MACF1,
CAPZA1), cellular aggregation (nuclear MSN and GSN
from cytoplasmic) and cellular assembly (the cytoplasmic
VPS28). Analysis of the molecular and cellular functions
shows that the proteins identified after the ingestion of
this diet are involved in cellular assembly and organization
(the nuclear PLEK and MSN, and the cytoplasmic GSN)
and cell death and survival (VPS28 and S100-A10 both
in cytoplasm). Likewise, analysis of the diseases and dis-
orders groups shows the proteins that are involved in
immunological diseases and inflammatory response. Ca-
nonical pathway analysis after the long-term intake of
LFHCC n-3 shows changes in the extrinsic prothrombin
activation pathway associated with the proteins differen-
tially expressed (p = 6.68E-05).
Discussion
Our study showed for the first time the effect of the long
term consumption of four dietary models, providing dif-
ferent quantity and quality of dietary lipids, on the whole
proteome of peripheral blood mononuclear cells (PBMC)
from patients with MetS. In this study, we analyzed separ-
ately the changes induced in the nuclear and cytoplasmic
proteome after the long-term consumption of a high satu-
rated fatty acid diet (HSFA), a high monounsaturated fatty
acids-rich diet (HMUFA), a low-fat high carbohydrates
diet (LFHCC) and a low-fat high carbohydrates diet
supplemented with n-3 fatty acids (LFHCC n-3).
Table 4 Correlation analysis between MetS and proteome changes
Parameter/Protein FGA F2 GSN PLEK CLIC1 CAPZ PSMA4
Triglycerides −0.611 −0.920 0.871 −0.750 0.971 −0.915 −0.841
0.197 0.009 0.024 0.086 0.006 0.030 0.075
Glucose 0.442 0.076 −0.624 −0.820 −0.785 0.951 0.879
0.380 0.886 0.185 0.046 0.116 0.013 0.049
Waist perimeter 0.894 0.518 −0.510 0.842 −0.303 0.579 0.775
0.041 0.371 0.301 0.036 0.697 0.421 0.124
Pearson correlation analysis between the fold change of the parameters of MetS and the fold change of the protein differentially expressed by the diets. FGA:
Alpha-fibrinogen precursor, F2: Chain B, Crystal Structure Of The Thrombin MutantG193p, GSN: Gelsolin isoform c, PLEK: Pleckstrin, CLIC1: Chloride intracellular
chanel 1 protein, CAPZ: Capping protein (actin filament) muscle Z-line, beta, PSMA4: PSMA4 protein
A B
Fig. 1 Interaction between induced proteins at the long-term consumption of (a) HSFA and (b) HMUFA diets. Networks of differentially expressed
proteins in the long-term ingestion of: a) HSFA, Saturated fatty acid diet; b) HMUFA, Monounsaturated fatty acid diet
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The proteins responding to the quantity and quality of
dietary lipids identified in our study showed that dietary
lipids regulate different biomechanisms directly involved
in the etiology of MetS. This idea is supported by the re-
lationship found between MetS parameters, mainly in
changes in the TAG and glucose levels and several
changes in the proteome. Long-term consumption of an
HSFA diet leads to the increase of a protein involved in
the degradation of ubiquitinilated proteins (nuclear
CHMP1.5, also known as VSP46; and cytoplasmic
TOM1), and DNA repair (POLR3E), both of which
mechanisms are activated in response to the oxidative
damage caused by reactive oxygen species (ROS). In
contrast, HMUFA, LFHCC and LFHCC n-3 diets showed
a decrease in the expression of proteins directly related
with oxidative stress, inflammation, endoplasmic reticulum
stress (ER) and DNA repair.
In terms of cellular function, the 56 differentially
expressed proteins after the consumption of the four diets
(nuclear and cytoplasmic fractions), are mainly involved in
four cellular processes: (1) movement, proliferation and
migration, (2) cellular assembly and organization, (3)
chaperones and oxidative stress response, and (4) DNA in-
tegrity. Similarly, these cellular mechanisms are related to
four biological pathways: inflammation, oxidative stress,
ER stress and DNA repair.
The long term consumption of the HSFA diet up-
regulated CHMP1.5 and TOM1 proteins, both involved
in the protein degradation by the ubiquitination system
in the ER. While CHMBP1.5 is involved in the formation
of multivesicular bodies (MVB) [25], TOM1 binds ubi-
quitin, which suggests that these proteins may partici-
pate in the sorting of ubiquitinated proteins into MVB
[26, 27]. In addition, the up-regulation after an HSFA
diet of POLR3E, an oxidative stress-induced protein, is
directly related with the DNA repair process after oxida-
tive damage [28]. Moreover, a pro-inflammatory effect of
HSFA consumption is suggested by the up-regulation of
the vasodilatador-stimulated protein (VASP) and the
down-regulation of ARPC2 and actin, both involved in
the control of migration and cellular aggregation charac-
teristic of inflammatory processes [29–31]. Additionally,
the up-regulation of the inflammatory-related NFX1 by
HSFA consumption reinforces the idea that oxidative
stress and inflammation are processes which are related
to each other [32].
In contrast, the long-term consumption of an HMUFA
diet down-regulated proteins involved in oxidative stress,
and prothrombotic and pro-inflammatory proteins. In
fact, there was a decrease in the expression of sortin-
associated protein 28 (VPS28), involved in the ubiquiti-
nation of damaged proteins by oxidative stress [33], and
POLR3E, a protein involved in DNA repair after oxida-
tive damage [34]. These results suggests that the lower
DNA damage after the long-term consumption of an
HMUFA diet is presumably due to lower oxidative stress
after the consumption of this diet, as previously de-
scribed [20, 35]. In keeping with this, a previous study
A B 
Fig. 2 Interaction between induced proteins at the long-term consumption of (a) LFHCC and (b) LFHCC n-3 diets. Networks of differentially expressed
proteins in the long-term ingestion of: a) LFHCC, Low fat, high-complex carbohydrate diet with placebo; b) LFHCC n-3, Low fat, high-complex
carbohydrate diet with 1.24 g/d LC n-3 PUFA diet
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by our group demonstrated in the same population as
this study an imbalance in the cellular redox state or
oxidative stress after an HSFA diet, with a reduction in
oxidative stress after HMUFA diet consumption [20].
In addition, the consumption of the HMUFA diet also
down-regulated seven proteins involved in thrombus
formation: prothrombin or coagulation factor II (F2),
fibrinogen (FGB), alpha-fibrinogen precursor (FGA),
Talin1 (TLN1) Gelsolin (GSN), Annexin2 (ANX2) and
Capping protein (actin filament) muscle Z-line, beta
(CAPZA1), which is especially important in MetS pa-
tients, as they are characterized by a pro-thrombotic
state [36]. In fact, high FGB levels are associated with an
increased risk of coronary artery disease and the patho-
genesis of myocardial infarction [37], and TLN1 partici-
pates in the establishment of focal cell to cell adhesions,
which are characteristic in the pro-thrombotic and in-
flammatory process [38]. On the other hand, ANX2 and
the capping protein actin (CAP) are involved in the acti-
vation of macrophages [39–41], and gelsolin (GSN) in
phagocytosis [42].
Both of the low-fat diets were characterized by a lower
activation of the inflammatory pathway. The changes in
the proteome observed after an HSFA diet support the
idea of an increased production of reactive oxygen spe-
cies, whereas changes in the proteome induced by
HMUFA reduced the risk of plaque formation of ather-
oma and reduced oxidative stress.
This is based on the down-regulation of TBK1, THBS-
1, FGB, TPM1, ACTB, and MYO1 proteins after LFHCC
consumption. TBK1 is a member of the IκB kinase
(IKK) family and plays an important role in the regula-
tion of the immune response [43, 44], THBS-1 has been
shown to promote platelet aggregation [45], and fibrino-
gen beta chain (FGB) protein, the substrate of the limit-
ing step in the production of mature fibrinogen which is
cleaved by thrombin to form insoluble fibrin, the most
abundant component of blood clots [46]. Proteins such
as actin (ACTB), myosin (MYO) and tropomyosin (TPM)
interact to form the extracellular matrix and provide
stability to the atherosclerotic plaque [47].
Moreover, the long-term consumption of both an
LFHCC diet and the HMUFA diet down-regulated the
REV3L protein, which participates actively in the repair
of DNA damage and is induced by a variety of stimuli,
including oxidative stress [48]. These results support the
idea that the long-term consumption of an LFHCC diet
reduces oxidative stress [20], which may prevent DNA
damage by ROS, as previously reported [35, 49]. Thus,
the long-term consumption of LFHCC n-3 diet down-
regulated proteins involved in cellular mechanisms such
as oxidative stress, inflammation and endoplasmic
reticulum function. Recent studies have demonstrated
that chloride intracellular channel 1 (CLIC1) has a
binding site for glutathione (GSH) in its N-terminal
domain and plays an important role in the generation
of ROS via the NADPH-oxidase system, participating
in the channel ion exchange required for the synthesis
of ROS [50]. Moreover, the long-term consumption of
an LFHCC n-3 diet also down-regulated S100-A10 pro-
tein, which forms a complex with annexin2, a mediator of
macrophage activation in the inflammatory response [51].
We also observed a down-regulation in MACF1 protein
after LFHCC n-3 diet consumption. This protein belongs
to the family of plakins and plays a role in the cytoskeletal
dynamic that is necessary for cell migration and chemo-
taxis, which are typical in mechanisms such as inflamma-
tion [52, 53]. Additionally, at ER level, the up-regulation
of BiP, an ER stress sensor protein [54], and the down-
regulation of HSP70, a protein involved in the transport
and folding of proteins in response to oxidative damage,
suggest a modulation of ER stress following the consump-
tion of LFHCC n-3.
One limitation of this study is that, although we are
able to identify protein profile changes indicative of the
modulations of the CVD risk factors associated with
MetS, further studies will be needed in order to work
out how to categorize diets according to their efficiency
as anti-inflammatory or antioxidant treatments, based
on the changes induced on the whole proteome.
Conclusion
The long term consumption of HSFA, compared to
HMUFA, LFHCC and LFHCC n-3, may increase the
CVD risk factors associated with metabolic syndrome,
such as inflammation and oxidative stress, in addition to
the DNA damage which is a consequence of high oxida-
tive stress. The implications of this study for the general
nutrition of the population, and specifically for MetS pa-
tients, lie in the adaptive effect observed after the long-
term consumption of four dietary models differing in the
quantity and quality of dietary lipids.
Methods
Participants and recruitment
We performed the current study within the framework
of the LIPGENE study (Diet, genomics and metabolic
syndrome: an integrated nutrition, agro-food, social and
economic analysis; Clinical Trial Registration Number:
NCT00429195 (Study identifier at ClinicalTrials.gov)), a
Framework 6 Integrated Projected funded by the Euro-
pean Union. All participants gave their written informed
consent and underwent a comprehensive medical his-
tory, physical examination and clinical chemical analysis
before enrolment. This study was carried out in the
Lipid and Atherosclerosis Unit of the Reina Sofia Uni-
versity Hospital, from February 2005 to April 2006. The
experimental protocol was approved by the Reina Sofia
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University Hospital Ethics Committee, according to the
Helsinki Declaration.
We analyzed the PBMC of a subgroup (24 MetS pa-
tients, 6 patients per diet, 3 women and 3 men) from
the LIPGENE Córdoba cohort, using 2-D proteomic
analysis. Sample size calculation was based on previous
studies in nutrition that examined the effects on the
whole proteome [23, 24].
Design, Randomization and intervention
The MetS patients were randomly stratified into 1 of 4
dietary models. MetS was defined by published criteria
[55], which conformed to the LIPGENE inclusion and
exclusion criteria [56]. Randomization was completed
centrally according to age, gender and fasting plasma
glucose concentration, using the Minimization Program
for Allocating Patients to Clinical Trials randomization
program (Department of Clinical Epidemiology, London
Hospital Medical College, UK).
The intervention study design and intervention proto-
col, which also provides information about pre-, mid-,
and post-intervention food consumption and dietary
compliance, have been described in detail by Shaw et al.
[56]. The dietary targets of the four isoenergetic diets
was as follows: the high saturated fatty acid (HSFA) diet
provided 38 % of total energy (E): 16 % SFA, 12 %
MUFA and 6 % PUFA; the high monounsaturated fatty
acid (HMUFA) diet provided 38 % of total E: 8 % SFA,
20 % MUFA and 6 % PUFA; the low-fat high-complex
carbohydrate (LFHCC) diet provided 28 % of total E:
8 % SFA 11 % MUFA and 6 % PUFA with 1 g/d high oleic
sunflower oil (placebo); and the low-fat, high-complex
carbohydrate diet (LFHCC n-3) provided 28 % of total E:
8 % SFA, 11 % MUFA, 6 % PUFA with 1.24 g/day long-
chain n-3 polyunsaturated fatty acids [19]. Participants
ingested the diet for which they were randomized over a
period of 12 weeks (Fig. 1), and the food intake and health
status of each participant were controlled by the medical
team. The dietary intake and compliance were assessed by
3-d (2 weekdays and 1 weekend day) weighed food intake
assessments at baseline, wk 6, and wk 12. The compos-
ition of the diet at the end of intervention period, as well
as the targets, have been previously described [20]. Blood
samples were taken on day 0 and after 12 weeks (day 84).
The patients arrived at the clinical center at 08:00 h, fol-
lowing a 12-h fast in which they refrained from smoking;
they had also abstained from alcohol intake during the
preceding 7 d.
Biochemical determinations of metabolic parameters
Lipid parameters were assessed with the modular autoana-
lyzer DDPPII Hitachi (Roche, Basel, Switzerland), using
specific reagents (Boehringer-Mannheim, Mannheim,
Germany). Determinations of total cholesterol (TC)
and triglycerides (TAG) levels were made by colorimetric
enzymatic methods [57, 58]; of high density lipoprotein-
cholesterol (HDL-c) by colorimetric assay [59]; of low
density lipoprotein-cholesterol (LDL-c) by the Friedewald
formula based on CT, TAG, and HDL-c values [60]. Plasma
glucose concentrations were measured with a Hitachi 917
analyzer (Boehringer Mannheim, Mannheim, Germany) by
the glucose oxidase method (GOD-PAP). Plasma insulin
concentrations were measured by microparticle enzyme
immunoassay (Abbott Diagnostics, Matsudo-shi, Japan).
Non-esterified fatty acid concentrations were measured by
enzymatic colorimetric assay (Roche Diagnostics, Penzberg,
Germany).
Isolation of peripheral blood mononuclear cells
Blood was collected in tubes containing 1 g of ethylene
diamine tetraacetic acid (EDTA)/L. The blood samples
were diluted 1:1 in phosphate saline buffer (PBS), and the
cells were isolated using Ficoll gradient by centrifugation
with Lymphoprep (Axis-Shield, Dundee, Scotland) at 800 x
g for 20 min at 20 °C. The peripheral blood mononuclear
cells were collected, washed with PBS and resuspended in
buffer A [mmol/L: 10 N-2 hydroxyethyl piperazine-N´-2-
ethanesulfonic acid (HEPES) pH 7.5, 10 KCl, 0.1 ethylene
glycol tetraacetic acid (EGTA), 0.1 EDTA, 1 dithiothreitol
(DTT), 0.5 phenylmethylsulfonyl fluoride (PMSF); and
cOmplete protease inhibitor cocktail Cat. No. 11697498001
(Roche Applied Science, Germany)] at −80 °C prior to
protein extraction.
Protein isolation from peripheral blood mononuclear cells
Cytoplasmic and nuclear fractions of protein from
PBMC were isolated following the protocol described by
Hernandez-Presa et al. [61]. The samples were thawed in
ice and mixed vigorously in a vortex and were then cen-
trifuged at 15.000 x g, 5 min, at 4 °C. After centrifuga-
tion, the supernatant was collected (protein cytoplasmic
fraction). The pellet was resuspended in 100 μL of lysis
buffer C (mmol/L: 20 HEPES pH 7.5, 400 NaCl, 1
EDTA, 1 EGTA, 1 DTT, 1 PMSF; and cOmplete prote-
ase inhibitor cocktail) and incubated for 20 min in ice,
during which period the samples were mixed vigorously
in a vortex every 5 min for 30 s. The protein nuclear
fraction was recovered from the supernatant after centri-
fugation at 10.000 x g, 5 min, at 4 °C. For protein quanti-
fication, we used the Bradford method using Dye
Reagent Protein (Bio-Rad Laboratories, Inc., Hercules,
CA, USA), following the manufacturer’s instructions.
Gel electrophoresis 2-D, imaging acquisition and spot
detection
Two-dimensional polyacrylamide gel electrophoresis was
performed as described by Görg et al. [62]. Briefly, 200 μg
of protein were diluted in 200 μl of Rehydratation buffer
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(8 M urea, 2 % CHAPS, 50 mM DTT, 0.2 % Bio-Lyte 3/10
ampholyte and 0.002 % bromophenol blue). Conditions of
IEF (isoelectric focussing, first dimension) and electro-
phoresis SDS-PAGE (second dimension) were performed
similarly, as previously described [24]. Gel staining was
performed overnight in darkness with SYPRO Ruby (Bio-
Rad Laboratories, Inc., Hercules, CA, USA) after protein
fixing using 40 % methanol and 10 % acetic acid for 2 h.
The gels were washed in 40 % methanol and 10 % acetic
acid twice for 1 h and once in distilled water for 30 min.
The gels were visualized with UV light using ChemiDoc
XRS System (Bio-Rad Laboratories, Inc., Hercules, CA,
USA). Images were acquired using Quantity One 16.0
software (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
The spots were detected using PDQuest 8.0.1 software
(Bio-Rad Laboratories, Inc., Hercules, CA, USA). The
normalization method chosen was total quantity in valid
spots, and we used the detection parameters previously
described [24].
MALDI-TOF MS analysis
The spots were excised automatically in a ProPic station
(Genomic Solutions, Huntingdon, UK) and subjected to
MS analysis. For MALDI-TOF-MS analysis, gel specimens
were unstained twice (30 min, 37 °C) with 200 mM am-
monium bicarbonate/40 % acetonitrile. Gel pieces, dehy-
drated for 5 min with pure acetonitrile and dried out for
4 h, were automatically digested with trypsin according
to the standard protocols in a ProGest station (Genomic
Solutions). MS and MS/MS peptide analyses of each
sample were taken in a 4700 Proteomics Station (Applied
Biosystems, CA, USA). Mass spectrometry was performed
at the Proteomics Facility (SCAI) of the University of
Cordoba, which is Node 6 of the ProteoRed Consortium
financed by Genoma España and belongs to the Andalusian
Platform for Genomics, Proteomics and Bioinformatics.
Pathway analysis
In order to investigate functional relationships in the set
of differentially expressed proteins, we used the Ingenuity
Pathway Analysis Software version 12.0 (Ingenuity
Systems, Redwood City, CA USA) [63], containing a
predefined data base which curates information on
over 10,000 human genes.
We performed analyses on three groups of proteins: 1)
all proteins included in the first list of proteins that
change significantly, regardless of the diet and the frac-
tion in which they were identified; 2) four lists of pro-
teins were created, one for each diet, independent of the
fraction in which these proteins were identified; 3) all
proteins identified in the nuclear fraction and other pro-
teins identified in the cytoplasm fraction, both independ-
ent of the diet. Core analysis was performed using the
Ingenuity Knowledge Base as a reference set of the gene
population, to consider to p-value calculations. We ana-
lyzed direct and indirect interactions using all the data
sources of the ingenuity pathway and only for humans.
Statistical analysis
2-D gel analysis was performed using PDQuest software
(Bio-Rad Laboratories), version 8.0. Manual corrections
were also performed to validate the matches automatic-
ally generated by the software. Spot volume values were
normalized in each gel by dividing the raw quantity of
each spot by the total volume of all valid spots included
in the same gel. Other normalizations provided by the
PDQuest software were also performed with similar
results. Statistical analysis was performed using PASW
Statistics, Version 18 (Chicago, IL, USA). The normal
distribution of variables to characterize differences in the
expression of proteins under study was assessed using the
Kolmogorov-Smirnov test followed by a Student’s t-test for
independent samples. Differences were considered signifi-
cant at p < 0.05. All data are expressed as mean ± S.E.M.
Additional files
Additional file 1: Table S1. Quantity and quality dietary fat long-term
effect on the proteome of the nuclear fraction of PBMC. Proteins differentially
expressed in the post-intervention compared to the baseline from an average
of over 250 protein spots detected in the nuclear fraction. FC: Fold
change. T-test p-value. UR, up-regulated proteins, not detected at baseline
but detected at post-intervention. DR, down- regulated, proteins detected
at baseline but not detected at post-intervention. MW: Molecular weight.
pI: Isoelectric point. SCI: Score C.I %. TI C.I: Total Ion C.I. %. Pep. Count: peptide
count. C.I.: Confidence index.
Additional file 2: Table S2. Quantity and quality dietary fat long-term
effect on the proteome of cytoplasmic fraction of PBMC. Proteins differentially
expressed in the post-intervention compared to the baseline from an average
of over 350 protein spots detected in the cytoplasmic fraction. FC: Fold
change. T-test p-value. UR, up-regulated proteins, not detected at baseline
but detected at post-intervention. DR, down- regulated, proteins detected at
baseline but not detected at post-intervention. MW: Molecular weight.
pI: Isoelectric point. SCI: Score C.I %. TI C.I: Total Ion C.I. %. Pep. Count:
peptide count. C.I.: Confidence index.
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